Mobile

To examine the discontinuation rates in women 18 to 35 years of age using LCS12 compared with discontinuation rates in women using the etonogestrel subdermal implant over 12 months. Additionally bleed...

Mise à jour : Il y a 4 ans
Référence : EUCTR2010-023911-32

To examine the discontinuation rates in women 18 to 35 years of age using LCS12 compared with discontinuation rates in women using the etonogestrel subdermal implant over 12 months. Additionally bleeding patterns, user satisfaction and adverse event profile will be assessed

Femme Homme

  • | Pays :
    • -
  • | Organes :
    • -
  • | Spécialités :
    • -

Extrait

The primary objective is to demonstrate that discontinuation rates in women (ages 18-35 years inclusive) using LCS12 are not higher than those seen in women using ENG subdermal implant over a period of 12 months.

Critère d'inclusion

  • The aim of the present study is to examine the discontinuation rates in women (ages 18-35, inclusive) using LCS12 compared with the discontinuation rates in women using the ENG subdermal contraceptive implant over 12 months

Liens